EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Feasibility and Safety of Washed Microbiota Transplantation as Salvage Therapy for Refractory Non‐ CDI Gut Pathogens in Critically Ill Patients

Jie Xu iD, Aoli Diao iD, Rujun Ai iD, Xia Wu iD, Quan Wen iD, Yuyan Xiao iD, Xinyi He iD, You Yu iD, Zulun Zhang iD, Yeqing Wang iD, Zhihua Zhang iD, Faming Zhang iD und 1 weitere

Microbial Biotechnology · 2026

DOI: 10.1111/1751-7915.70431 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Biotechnology, 2026. Verfasst von Jie Xu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Sir Run Run Hospital, Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Salvage Therapy, Fecal Microbiota Transplantation, Critical Illness. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Jiangsu Province, Jiangsu Provincial Health Commission, Jiangsu Commission of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Limited treatment options exist for refractory non‐ Clostridioides difficile infection (non‐CDI) of the gut in critically ill patients; whether washed microbiota transplantation (WMT) is feasible and safe in this heterogeneous population is unknown. We retrospectively analysed prospectively registered consecutive cases (NCT03895593) between September 2015 and August 2022, in which severe non‐CDI gut pathogens were identified, and rescue WMT was administered after standard treatment failure. Primary outcomes were the clinical outcome and adverse events graded by CTCAE v5.0. Secondary descriptive outcomes were the change in total abdominal symptom score (TASS) on day 7, microbiological clearance, and 12‐week survival. Ten patients underwent 29 WMT infusions. Fifty percentage of patients (5/10) obtained clinical cure after WMT. Twenty percentage of patients (2/10) achieved clinical improvement and 30% (3/10) showed no response 7 days after WMT. One transient WMT‐related fever occurred (1/29, 3.45%). No serious WMT‐attributed events were observed. TASS decreased significantly ( p = 0.007). Microbiological clearance was documented in 3 of 4 patients with available post‐WMT stool bacteriological test results. This case series provides preliminary evidence supporting the feasibility and potential efficacy of WMT for refractory non‐CDI gut pathogens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Salvage TherapyFecal Microbiota TransplantationCritical IllnessHumansFemaleRetrospective StudiesMaleMiddle AgedTreatment OutcomeAgedFeasibility StudiesAdultFeces

Stichwörter der Autor:innen

faecal microbiota transplantationgut infectiongut microbiotapathogen decolonizationsalvage therapy

Autor:innen und Institutionen

  • Department of Gastroenterology, Sir Run Run Hospital, Nanjing Medical University, Nanjing, China.
  • Department of Microbiota Medicine and Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Key Lab of Holistic Integrative Enterology, Nanjing Medical University, Nanjing, China.
  • Department of Gastroenterology, Punan Branch of Renji Hospital, Shanghai Jiao Tong University School of Medicine (Punan Hospital in Pudong New District, Shanghai), Shanghai, China.
  • Pediatric Intensive Care Unit, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
  • Department of Digestive, Children's Hospital of Nanjing Medical University, Nanjing, China.

ORCID-Profile: Jie Xu, Aoli Diao, Rujun Ai, Xia Wu, Quan Wen, Yuyan Xiao, Xinyi He, You Yu, Zulun Zhang, Yeqing Wang, Zhihua Zhang, Faming Zhang, Bota Cui

Förderung

  • Natural Science Foundation of Jiangsu Province
  • Jiangsu Provincial Health Commission
  • Jiangsu Commission of Health

Zitieren

APA

Xu, J., Diao, A., Ai, R., Wu, X., Wen, Q., Xiao, Y., He, X., Yu, Y., Zhang, Z., Wang, Y., Zhang, Z., Zhang, F., & Cui, B. (2026). Feasibility and Safety of Washed Microbiota Transplantation as Salvage Therapy for Refractory Non‐ CDI Gut Pathogens in Critically Ill Patients. Microbial Biotechnology. https://doi.org/10.1111/1751-7915.70431

Vancouver

Xu J, Diao A, Ai R, Wu X, Wen Q, Xiao Y, et al. Feasibility and Safety of Washed Microbiota Transplantation as Salvage Therapy for Refractory Non‐ CDI Gut Pathogens in Critically Ill Patients. Microbial Biotechnology. 2026. doi:10.1111/1751-7915.70431

BibTeX
@article{Xu2026,
  author = {Xu, Jie and Diao, Aoli and Ai, Rujun and Wu, Xia and Wen, Quan and Xiao, Yuyan and He, Xinyi and Yu, You and Zhang, Zulun and Wang, Yeqing and Zhang, Zhihua and Zhang, Faming and Cui, Bota},
  title = {Feasibility and Safety of Washed Microbiota Transplantation as Salvage Therapy for Refractory Non‐ CDI Gut Pathogens in Critically Ill Patients},
  journal = {Microbial Biotechnology},
  year = {2026},
  doi = {10.1111/1751-7915.70431}
}
Kostenlos starten →